Lung cancer in HIV positive patients: The GICAT experience

European Review for Medical and Pharmacological Sciences

Volumn 18, Issue 4, 2014, Pages 500-508

  Bearz, A ^a   Vaccher, E ^a   Martellotta, F ^a   Spina, M ^a   Talamini, R ^a   Lleshi, A ^a   Cacopardo, B ^b   Nunnari, G ^b   Berretta, M ^a,c   Tirelli, U ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

^c Euro Mediterranean Institute of Science and Technology   (Italy)

Author keywords

Chemotherapy; HAART; HIV; Lung cancer

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DIDANOSINE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; GEMCITABINE; INDINAVIR; LAMIVUDINE; NAVELBINE; SAQUINAVIR; STAVUDINE; VINCRISTINE; ZIDOVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CAUSE OF DEATH; CONTROLLED STUDY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG CANCER; LUNG LOBECTOMY; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; OVERALL SURVIVAL; TREATMENT RESPONSE; ADVERSE EFFECTS; AGED; CHEMORADIOTHERAPY; COMPARATIVE STUDY; EPIDEMIOLOGY; HEALTH CARE SURVEY; HIV INFECTIONS; ITALY; KAPLAN MEIER METHOD; KARNOFSKY PERFORMANCE STATUS; LUNG NEOPLASMS; MORTALITY; QUESTIONNAIRE; RISK FACTOR; TIME; TREATMENT OUTCOME;

ADULT; AGED; ANTI-HIV AGENTS; ANTINEOPLASTIC AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CAUSE OF DEATH; CHEMORADIOTHERAPY; FEMALE; HEALTH CARE SURVEYS; HIV INFECTIONS; HIV LONG-TERM SURVIVORS; HUMANS; ITALY; KAPLAN-MEIER ESTIMATE; KARNOFSKY PERFORMANCE STATUS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PNEUMONECTOMY; QUESTIONNAIRES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84896974637     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. BERRETTA M, CINELLI R, MARTELLOTTA F, SPINA M, VACCHER E, TIRELLI U. Therapeutic approaches to AIDSrelated malignancies. Oncogene 2003; 22: 6646-6659.
2. LA FETA L, PINZONE MR, NUNNARI G, MARTELLOTTA F, LLLESHI A, TIRELLI U, DE PAOLI P, BERRETTA M, CACOPARDO B. Kaposi's sarcoma in HIV-positive patients: the state of art in the HAART-era. Eur Rev Med Pharmacol Sci 2013; 17: 2354-2365.
3. MARTELLOTTA F, BERRETTA M, VACCHER E, SCHIOPPA O, ZANET E, TIRELLI U. AIDS-related Kaposi's sarcoma: state of the art and therapeutic strategies. Curr HIV Res 2009; 7: 634-638.
4. SIMONELLI C, TEDESCHI R, GOGHINI A, TALAMINI R, BORTOLIN MT, BERRETTA M, SPINA M, MORASSUT S, VACCHER E, DE PAOLI P, CARBONE A, TIRELLI U. Plasma HHV-8 viral load in HHV-8-related lymphoproliferative disorders associated with HIV infection. J Med Virol 2009; 81: 888-896.
5. DI BENEDETTO F, DI SANDRO S, DE RUVO N, BERRETTA M, MASETTI M, MONTALTI R, BALLARIN R, COCCHI S, POTENZA L, LUPPI M, GERUNDA GE. Kaposi's sarcoma after liver transplantation. J Cancer Res Clin Oncol 2008; 134: 635-638.
6. NASTI G, MARTELLOTTA F, BERRETTA M, MENA M, FASAN M, DI PERRI G, TALAMINI R, PAGANO G, MONTRONI M, CINELLI R, VACCHER E, D'ARMINIO MONFORTE A, TIRELLI U. Impact of HAART on the presenting features and outcome of patients with acquired immunodeficiency syndrome-related Kaposi sarcoma. Cancer 2003; 98: 2440-2446.
7. KAPLAN LD. AIDS-associated lymphomas. AIDS Clin Rev 1991; 181-195.
8. Moore RD, Kessler H, Richmann DD, Flexner C, Chaisson RE. Non-Hodgkin's lymphoma in patients with advanced HIV treated with zidovudine. JAMA 1991; 65: 2208-2211.
9. KAHN JO. AIDS-associated Kaposi's sarcoma. AIDS Clin Rev 1990; 115-128.
10. BRODT HR, KAMPS DS, GUTE P, KNUPP B, STASZEWSKI S, HELM EB. Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy. AIDS 1997; 15: 1731-1738.
11. JOHNSON CC, WILCOSKY T, KVALE P, ROSEN M, STANSELL J, GLASSROTH J, REICHMAN L, WALLACE J, MARKOWITZ N, THOMPSON JE, HOPEWELL P. Cancer incidence among an HIV-infected cohort. Am J Epidemiol 1997; 146: 470-475.
12. BERRETTA M, DI BENEDETTO F, DAL MASO L, CACOPARDO B, NASTI G, FACCHINI G, BEARZ A, SPINA M, GARLASSI E, DE RE V, FIORICA F, LLESHI A, TIRELLI U. Sorafenib for the treatment of unresectable hepatocellular carcinoma in HIV-positive patients. Anticancer Drugs 2013; 24: 212-218.
13. MARTELLOTTA F, BERRETTA M, CACOPARDO B, FISICHELLA R, SCHIOPPA O, ZANHI A, SPARTÀ D, CAPPELLANI A, TALAMINI R, IZZI I, RIDOLFO A, TORRESIN A, FIORICA F, TIRELLI U. Clinical presentation and out come of squamous cell carcinoma of the anus in HIV-infected patients in the HAART-era: a GICAT experience. Eur Rev Med Pharmacol Sci 2012; 16: 1283-1291.
14. NUNNARI G, BERRETTA M, PINZONE MR, DI ROSA M, BERRETTA S, CUNSOLO G, MALAGUARNERA M, COSENTINO S, DE PAOLI P, SCHNELL JM, CACOPARDO B. Hepatocellular carcinoma in HIV positive patients. Eur Rev Med Pharmacol Sci 2012; 16: 1257-1270.
15. ZANET E, BERRETTA M, BENEDETTO FD, TALAMINI R, BALLARIN R, NUNNARI G, BERRETTA S, RIDOLFO A, LLESHI A, ZANGHÌ A, CAPPELLANI A, TIRELLI U. Pancreatic cancer in HIV-positive patients: a clinical case-control study. Pancreas 2012; 41: 1331-1335.
16. BEARZ A, VACCHER E, TALAMINI R, BERRETTA M, TIRELLI U. Comment on Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infection. Br J Cancer 2012; 106: 1899-1900.
17. BERRETTA M, GARLASSI E, CACOPARDO B, CAPPELLANI A, GUARALDI G, COCCHI S, DE PAOLI P, LLESHI A, IZZI I, TORRESIN A, DI GANGI P, PIETRANGELO A, FERRARI M, BEARZ A, BERRETTA S, NASTI G, DI BENEDETTO F, BALESTRERI L, TIRELLI U, VENTURA P. Hepatocellular carcinoma in HIV-infected patients: check early, treat hard. Oncologist 2011; 16: 1258-1269.
18. ZANET E, BERRETTA M, MARTELLOTTA F, CACOPARDO B, FISICHELLA R, TAVIO M, BERRETTA S, TIRELLI U. Anal cancer: Focus on HIV-positive patients in the HAART era. Curr HIV Res 2011; 9: 70-81.
19. BEARZ A, LLESHI A, PERIN T, FRATINO L, VENTURINI S, GIACALONE A, SARTOR I, BERRETTA M, SULFARO S, TIRELLI U. Small cell lung cancer in an elderly patient: efficacy of somatostatin analog treatment. A case report. Onkologie 2011; 34: 117-120.
20. TAVIO M, GROSSI P, BACCARANI U, SCUDELLER L, PEA F, BERRETTA M, ADANI G, VIVARELLI M, RIVA A, TIRELLI U, BRESADOLA V, VIALE P, RISALITI A. HIV-infected patients and liver transplantation: who, when and why. Curr HIV Res 2011; 9: 120-127.
21. BERRETTA M, CAPPELLANI A, DI BENEDETTO F, LLESHI A, TALAMINI R, CANZONIERI V, ZANET E, BEARZ A, NASTI G, LACCHIN T, BERRETTA S, FISICHELLA R, BALESTRERI L, TORRESIN A, IZZI I, ORTOLANI P, TIRELLI U. Clinical presentation and out come of colorectal cancer in HIVpositive patients: a clinical case-control study. Onkologie 2009; 32: 319-324.
22. BERRETTA M, ZANET E, TAIBI R, MARTELLOTTA F, PAVONE P, BEARZ A, GOBITTI C, CIANCIA EM, CANZONIERI V, TIRELLI U. Leiomyosarcoma of the parotid gland in an HIV-positive patient: therapeutic approach, clinical course and review of the literature. J Chemother 2009; 21: 215-218.
23. DI BENEDETTO F, DI SANDRO S, DE RUVO N, BERRETTA M, MONTALTI R, GUERRINI GP, BALLARIN R, DE BLASIIS MG, SPAGGIARI M, SMERIERI N, IEMMOLO RM, GUARALDI G, GERUNDA GE. Human immunodeficiency virus and liver transplantation: our point of view. Transplant Proc 2008; 40: 1965-1971.
24. BERRETTA M, DI BENEDETTO F, BEARZ A, SIMONELLI C, MARTELLOTTA F, DEL BEN C, BERRETTA S, SPINA M, TIRELLI U. FOLFOX-4 regimen with concomitant HAART in metastatic colorectal cancer HIV-infected patients: a report of five cases and review of the literature. Cancer Invest 2008; 26: 610-614.
25. DI BENEDETTO F, DE RUVO N, BERRETTA M, MASETTI M, MONTALTI R, DI SANDRO S, BALLARIN R, CODELUPPI M, GUARALDI G, GERUNDA GE. Hepatocellular carcinoma in HIV patients treated by liver transplantation. Eur J Surg Oncol 2008; 34: 422-427.
26. SERRAINO D, PEZZOTTI P, DORRUCCI M, ALLIEGRO MB, SINICCO A, REZZA G. Cancer incidence in a cohort of human immunodeficiency virus seroconverters. HIV Italian Seroconversion Study Group. Cancer 1997; 79: 1004-1007.
27. LOUIE JK, HSU LC, OSMOND DH, KATZ MH, SCHWARCZ SK. Trends in causes of death among persons with acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy, San Francisco, 1994-1998. J Infect Dis 2002; 186: 1023-1027.
28. GRULICH AE, WAN X, LAW MG, COATES M, KALDOR JM. Risk of cancer in people with AIDS. AIDS. 1999; 13: 839-843.
29. FRISCH M, BIGGAR RJ, ENGELS EA GOEDERT JJ; AIDSCANCER MATCH REGISTRY STUDY GROUP. Association of cancer with AIDS-related immunosuppression in adults. JAMA 2001; 285: 1736-1745.
30. HERIDA M, MARY-KRAUSE M, KAPHAN R, CADRANEL J, POIZOT-MARTIN I, RABAUD C, PLAISANCE N, TISSOTDUPONT H, BOUE F, LANG JM, COSTAGLIOLA D. Incidence of non-AIDS defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients. J Clin Oncol 2003, 21: 3447-3453.
31. TIRELLI U, SPINA M, SANDRI S SERRAINO D, GOBITTI C, FASAN M, SINICCO A, GARAVELLI P, RIDOLFO AL, VACCHER E. Lung carcinoma in 36 patients with human immunodeficiency virus infection. The Italian Cooperative Group on AIDS and Tumors. Cancer 2000; 88: 563-569.
32. DAL MASO L, POLESEL J, SERRAINO D, FRANCESCHI S. Lung cancer in persons with AIDS in Italy, 1985-1998 HIV. AIDS 2003, 17: 2117-2119.
33. SOBIN LH, WITTEKIND CH. TNM Classification of Malignant Tumors. John Wiley and Sons, Hoboken, New Jersey, 2002.
34. DOMOK R. FROM THE CENTERS FOR DISEASE CONTROL AND PREVENTION. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. JAMA 1993; 269: 729-730.
35. MILLER AB, HOOGSTRATEN B, STAQUET M, WINKLER A. Reporting results of cancer treatment. Cancer 1981; 47: 207-214.
36. KAPLAN EL, MEIER P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
37. MANTEL N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966; 50: 163-170.
38. ARMITAGE P, BERRY G. Statistical methods in medical research. Blackwell Sc. Publication, 1987.
39. BUCCHERI G, FERRIGNO D. Lung cancer in north west Italy: demographic and clinical trends in a hospital-based population of 1277 patients. Eur J Cancer Prev 2003; 12: 455-461.
40. POWLES T, NELSON M, BOWLER M. HIV related lung cancer: a growing concern. Int J St AIDS 2003; 14: 647-651.
41. OSANN KE. Epidemiology of lung cancer. Curr Opinion Pulm Med 1998; 4: 198-204.
42. KREUZER M, KREIENBROCK L, MULLER KM, GERKEN M, WICHMANN E. Histologic types of lung carcinoma and age at onset. Cancer 1999; 85: 1958-1965.
43. NON SMALL CELL LUNG CANCER COLLABORATIVE GROUP. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Br Med J 1995; 311: 899-909.
44. FLEXNER C. HIV-protease inhibitors. N Engl J Med 1998; 338: 1281-1292.
45. WASHINGTON CB, DURAN GE, MAN MC, SIKIC BI, BLASCHKE TF. Interaction of anti-HIV protease inhibitors with the multidrug transposter P-glycoprotein (P-gp) in human cultured cells. J AIDS Hum Retrovirol 1998; 19: 203-209.
46. TULPULE A. Multicenter trial of low dose paclitaxel in patients with advanced AIDS-related Kaposi sarcoma. Cancer 2002; 95: 147-154.
47. GILL PS, TULPULE A, ESPINA BM, CABRIALES S, BRESNAHAN J, ILAW M, LOUIE S, GUSTAFSON NF, BROWN MA, ORCUTT C, WINOGRAD B, SCADDEN DT. Paclitaxel is safe and effective in the treatment of advanced AIDS-related Kaposi's sarcoma. J Clin Oncol 1999; 17: 1876-1883.
48. VACCHER E, SPINA M, DI GENNARO TALAMINI R, NASTI G, SCHIOPPA O, VULTAGGIO G, TIRELLI U. Concomitant cyclophosphamide, doxorubicin, vincristin and prednisone chemotherapy, plus highly active retroviral therapy in patients with human immunodeficiency virus-related, non Hodgkin lymphoma. Cancer 2001; 91: 155-163.
49. RATNER L, LEE J, TANG S, REDDEN D, HAMZEH F, HERNDIER B, SCADDEN D, KAPLAN L, AMBINDER R, LEVINE A, HARRINGTON W, GROCHOW L, FLEXNER C, TAN B, STRAUS D; AIDS MALIGNANCY CONSORTIUM. Chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma in combination with highly active antiretroviral therapy. J Clin Oncol 2001; 8: 2171-2217.
50. SOCINSKI M. The role of chemotherapy in the treatment of unresectable stage III and IV non small cell lung cancer. Respir Care Clin N Am 2003; 9: 207-236.